News
Fourteen-day sports hiatus recommended for children after COVID-19
October 13, 2020
Children with moderate symptoms should have an electrocardiogram before returning to sports.
News
Empagliflozin cut PA pressures in heart failure patients
October 12, 2020
The drops in pulmonary artery pressure were modest but large enough to be clinically meaningful, they appeared quickly, and increased over time.
News
Remdesivir effective, well-tolerated in final trial report
October 9, 2020
A 50% greater likelihood of significant clinical improvement within 15 days occurs with taking remdesivir versus placebo.
News
More data on impact of corticosteroids on COVID-19 mortality in patients with COPD
October 9, 2020
Patients with COPD or asthma who used ICS on a regular basis were more likely to die from COVID-19.
News
COVID-19 vaccine hesitancy ‘somewhat understandable,’ expert says
October 8, 2020
Dr. Offit predicts a vaccine may be able to be 75%-80% effective at preventing mild to moderate disease.
News
Pediatric fractures shift during pandemic
October 8, 2020
Yet there were more bone fractures at home and on bicycles, and more fractures in younger children.
News
One measure of child COVID-19 may be trending downward
October 8, 2020
Percentage of weekly cases occurring in children has dropped for 2 consecutive weeks.
News
CMS gives hospitals 14 weeks to start daily COVID, flu reports
October 7, 2020
The Centers for Medicare & Medicaid Services (CMS) will send letters on October 7 to all 6,200 hospitals that receive reimbursement from the two federal health programs informing them of how well they are doing now.
News
Optimal sedation strategies for COVID-19 ICU patients: A work in progress
October 7, 2020
“Clinicians should consider using adjuvant agents to limit opioid exposure and improve pain scores in the critically ill,” Dr. Steven B. Greenberg said.
News
FDA posts COVID vaccine guidance amid White House pushback
October 7, 2020
In the new guidance document, FDA officials outline what will be required for even a limited clearance, known as an emergency use authorization, for a COVID-19 vaccine.